Rising Pharmaceuticals Inc., a finished dosage form generics subsidiary of ACETO Corporation, has launched the 200mg/325mg strengths of carisoprodol and Aspirin tablets, USP, an approved generic version of Meda Pharmaceutical's Soma compound with Aspirin tablets, and 10/gr Sodium Bicarbonate Tablets, USP.

According to data, US market sales for Carisoprodol and Aspirin Tablets, USP, used to relieve pain, muscle spasm and limited mobility associated with acute painful musculoskeletal conditions, and Sodium Bicarbonate Tablets, USP, an antacid used to relieve heartburn and acid indigestion, were approximately collectively for the 12 months ended.

ACETO Corporation, a global leader in the marketing, sales and distribution of pharmaceutical active ingredients and intermediates, finished dosage form generic pharmaceuticals, nutraceutical products, agricultural protection products and specialty chemicals.